Herlev, Denmark

Brian Kobmann

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novozymes A/s. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Kobmann. Retrieved from https://idiyas.com/inventor/brian-kobmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Kobmann: Innovator in Bacterial Mutants

Introduction

Brian Kobmann is a notable inventor based in Herlev, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of bacterial mutants with enhanced transformation efficiency. His work is crucial for advancing genetic engineering and microbial applications.

Latest Patents

Kobmann holds a patent titled "Bacterial mutants with improved transformation efficiency." This patent describes mutants that possess a disruption to an endogenous gene encoding a restriction modification system protein. The patent also outlines methods for producing these mutants, generating transformants using them, and producing polypeptides or fermentation products.

Career Highlights

Brian Kobmann is associated with Novozymes A/S, a leading company in the biotechnology sector. His role at Novozymes allows him to apply his innovative ideas in a practical setting, contributing to the company's mission of sustainable solutions through biotechnology.

Collaborations

Kobmann has worked alongside esteemed colleagues such as Steen Troels Joergensen and Torsten Bak Regueira. Their collaboration fosters a dynamic environment for research and development, enhancing the impact of their collective work.

Conclusion

Brian Kobmann's contributions to the field of biotechnology through his patent and work at Novozymes A/S highlight his role as an innovator. His research on bacterial mutants is paving the way for advancements in genetic engineering and microbial applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…